Pfizer initiates dosing in Phase III prostate cancer drug trial
TALAPRO-3 will enrol 550 men with DDR-deficient mCSPC at about 285 sites in 28 countries.
News
Quantum computers, here but not here – what businesses need to know
The interest around quantum computing continues to grow, but many still see it as something...
Veradigm and PRA Health create EHR-based clinical research network
The partnership could boost process efficiencies, accessibility and diversity of clinical trials.
US NIH trials Covid-19 vaccines in pregnant participants
The study will also evaluate the transfer of vaccine-generated antibodies to infants via breast milk.
Senhwa seeks India’s CDSCO approval for Phase II Covid-19 drug trial
The trial will assess the safety, clinical benefit and anti-viral activity of Silmitasertib in 50...
Sanofi and Translate Bio commence Phase I influenza vaccine trial
The trial is part of the companies’ partnership to develop mRNA vaccines for various infectious diseases.
Covaxin Phase III data shows jab to be 77.8% effective ahead of WHO meeting
India’s first indigenous vaccine comes out as 77.8% effective in Phase III trials, just in time for a WHO meeting.
Histogen-Amerimmune’s emricasan yields positive results in Covid-19 trial
The drug offered resolution of all symptoms linked to mild Covid-19 and retained it until day 45.
UK announces funding support to bolster clinical research
The first-year activity will involve the development and trials of new treatments and vaccines for Covid-19.
Oxford University adds ivermectin to PRINCIPLE trial for Covid-19
Ivermectin is a broad spectrum antiparasitic that reduced SARS-CoV-2 replication in laboratory studies.
Roche Alzheimer’s drug yields mixed results in WUSTL study
Trial subjects who were given gantenerumab experienced a slow rise in neurofilament light chain levels in cerebrospinal fluid.
